Boothbay Fund Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Hold |
240,873
| – | – | ﹤0.01% | 1078 |
|
|
2025
Q1 | $263K | Sell |
240,873
-184,441
| -43% | -$201K | 0.01% | 932 |
|
|
2024
Q4 | $425K | Buy |
425,314
+1,792
| +0.4% | +$1.79K | 0.01% | 793 |
|
|
2024
Q3 | $699K | Hold |
423,522
| – | – | 0.02% | 722 |
|
|
2024
Q2 | $470K | Hold |
423,522
| – | – | 0.01% | 878 |
|
|
2024
Q1 | $559K | Buy |
423,522
+342,431
| +422% | +$452K | 0.01% | 833 |
|
|
2023
Q4 | $122K | Hold |
81,091
| – | – | ﹤0.01% | 1245 |
|
|
2023
Q3 | $119K | Sell |
81,091
-36,039
| -31% | -$53K | ﹤0.01% | 1331 |
|
|
2023
Q2 | $294K | Hold |
117,130
| – | – | 0.01% | 1113 |
|
|
2023
Q1 | $175K | Hold |
117,130
| – | – | ﹤0.01% | 1547 |
|
|
2022
Q4 | $164K | Buy |
+117,130
| New | +$164K | ﹤0.01% | 1426 |
|
|
2022
Q3 | – | Sell |
-17,831
| Closed | -$62K | – | 2102 |
|
|
2022
Q2 | $62K | Buy |
+17,831
| New | +$62K | ﹤0.01% | 1789 |
|
|
2021
Q4 | – | Sell |
-17,469
| Closed | -$155K | – | 1831 |
|
|
2021
Q3 | $155K | Buy |
+17,469
| New | +$155K | ﹤0.01% | 1415 |
|
|
2019
Q1 | – | Sell |
-655
| Closed | -$5K | – | 712 |
|
|
2018
Q4 | $5K | Buy |
655
+385
| +143% | +$2.94K | ﹤0.01% | 549 |
|
|
2018
Q3 | $3K | Buy |
+270
| New | +$3K | ﹤0.01% | 639 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 692 |
|